Clinical Trial

Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation

Study acronym: MS-HDtDCS
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., presupplementary motor area) thought to aid in memory will improve verbal retrieval in multiple sclerosis patients. The primary outcome measures are neuropsychological assessments of verbal retrieval, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures. Additionally, the study will examine the degree to which baseline assessments of cognition and concussion history predict responses to treatment over time, both on assessments administered within the intervention period and at follow-up.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-06-29 -> 2027-06-29 2026-08-15
Trial Details
NCT Number NCT05958381
Lead Sponsor The University of Texas at Dallas
Collaborators: University of Texas Southwestern Medical Center
Conditions Multiple Sclerosis, Relapsing-Remitting
Enrollment 100 participants
Start Date 2023-10-18
Primary Completion 2027-06-29 (estimated)
Study Completion 2027-06-29 (estimated)
Updated on ClinicalTrials.gov 2026-08-14